BK Technologies insider sale; Suzuki retains 42,896 shares and 218,391 options
Rhea-AI Filing Summary
John M. Suzuki, CEO & President and a director of BK Technologies Corp (BKTI), reported a sale of company stock on 08/22/2025. He disposed of 3,000 shares of common stock at $70 per share, leaving him with 42,896 shares beneficially owned after the transaction. The filing also discloses a portfolio of outstanding stock options exercisable into 218,391 shares in aggregate across six option grants with exercise prices ranging from $11.65 to $42.81 and various vesting schedules, including time-based and performance-based vesting.
The Form 4 is a routine insider disclosure of ownership changes and option holdings; it documents the specific transaction, Suzuki’s roles with the issuer, and the vesting/expiration details provided for each option grant.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider sale of 3,000 shares at $70 is disclosed; material impact appears limited given remaining holdings and option exposure.
Mr. Suzuki reported a modest sale relative to his post-transaction holding of 42,896 shares. The Form 4 transparently lists vested and unvested option positions totaling 218,391 underlying shares with exercise prices from $11.65 to $42.81 and mixed vesting triggers, including performance conditions. From a capital-structure perspective, the disclosed option overhang is quantifiable and sizable in absolute terms, but the filing provides no company financials or indications of intent beyond the single sale. This is a routine disclosure useful for calculating potential dilution and short-term insider liquidity but contains no standalone financial performance data.
TL;DR: Disclosure complies with Section 16 reporting; sale and option grants are documented with vesting details and signature.
The Form 4 clearly identifies the reporting person, his roles as CEO, President and director, and provides transaction date, type (sale), price and resulting beneficial ownership. The filing includes thorough explanatory notes on vesting conditions, including performance-based vesting and change-in-control provisions. For governance monitoring, this supports transparency around insider transactions and executive compensation structure; it raises no procedural concerns in the filing itself.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,000 | $70.00 | $210K |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Footnotes (1)
- The option is fully vested. The options were granted on March 1, 2022, and vest in five equal annual installments, beginning on March 1, 2022. The options were granted on June 22, 2022, and will vest immediately upon a change in control that occurs on or before the five-year anniversary of the date of grant. The options were granted on July 11, 2023, and vest in five equal annual installments, beginning on July 11, 2024. The options were granted on February 6, 2024, and vest in five equal annual installments, beginning on February 6, 2025. The option will vest and become exercisable upon achievement of certain performance-based stock price hurdles and continued employment with the issuer during the five-year performance period ending on July 10, 2030, subject to earlier vesting upon certain qualifying termination events.
